TMPRSS2 and neoplasm: Moreover, Ki67 proliferation marker was also decreased in tumours treated with NPs siRNA TMPRSS2-ERG IV-SQ (Fig 5d), indicating a reduction of mitotic index by vectorized siRNA TMPRSS2-ERG treatment.